Odontogenic keratocysts (OKCs), initially referred to as Keratocystic Odontogenic Tumors (KCOTs), have been a subject of intense study and clinical interest for many decades. The evolution of their name from KCOTs to OKCs is more than a mere rebranding; it represents a significant shift in the understanding of these entities, recognizing their origins and distinct clinical behavior. These cysts, embedded in the complex landscape of odontogenic pathologies, stand out due to their unique developmental nature, which is intricately linked to their clinical and histopathological features. This evolution in nomenclature has profound implications in both the academic and clinical realms, guiding research and influencing treatment approaches [1,2].

The clinical significance of OKCs cannot be overstated. They are notorious for their aggressive behavior, which is manifest not just in their potential for sizeable growth but also in their tendency to recur, even after surgical intervention. This recurrence is not merely a matter of pathological interest but carries substantial functional and esthetic implications for patients. In some cases, OKCs can lead to significant deformation of the jaw, displacement or resorption of teeth and can even impact facial symmetry and aesthetics. These physical manifestations are accompanied by a spectrum of psychological impacts, ranging from mild anxiety to severe psychological distress, especially in cases of recurrent cysts or those requiring extensive surgical intervention [2,3].

Understanding OKCs demands a comprehensive approach that delves into their diagnosis and management, as well as the molecular mechanisms underpinning their development. The journey from suspicion to confirmation of an OKC diagnosis is a meticulous process, involving a combination of clinical assessment, radiographic evaluation and histopathological examination. Each of these steps is crucial and complements the others; for instance, while radiographic imaging can reveal the extent and nature of the cyst, histopathology can confirm its specific type and guide treatment decisions. The management of OKCs is equally complex, often requiring a balance between the need for aggressive treatment to prevent recurrence and the desire to preserve function and aesthetics. This delicate balancing act is a challenge for clinicians, who must also consider the patient's overall health, preferences and the potential impact of treatment on their quality of life [2,4].            

Furthermore, the intrigue surrounding OKCs extends into their molecular landscape. Recent research has shed light on the genetic and molecular pathways involved in the development of these cysts, offering insights into their aggressive nature and propensity for recurrence. Understanding these molecular mechanisms is not just of academic interest but has practical implications, offering the potential for targeted therapies and more personalized treatment approaches. This molecular understanding also opens the door to interdisciplinary collaboration, bringing together experts in genetics, molecular biology, oral and maxillofacial surgery and pathology to forge new paths in the management of OKCs [3,4].

Odontogenic keratocysts represent a fascinating yet challenging area in oral and maxillofacial pathology. Their study offers a window into the complex interplay between developmental biology, genetics and clinical practice. As we continue to explore these cysts, their management is likely to evolve, informed by ongoing research and a deeper understanding of their unique characteristics. This journey of discovery is not only crucial for advancing our scientific knowledge but also for enhancing patient care, ensuring that individuals affected by OKCs receive the most effective and personalized treatments available.

Clinical Presentation of Odontogenic Keratocysts (OKCs)

Odontogenic Keratocysts (OKCs) present a unique clinical profile that has been the subject of extensive study in the realm of oral pathology. Predominantly emerging in the second and third decades of life, they exhibit a subtle but notable preference for affecting males over females. This demographic predilection offers intriguing insights into the potential hormonal or genetic factors that might influence the development of these cysts. OKCs are most commonly located in the posterior region of the mandible, an area known for its complex anatomical structures. A significant association with impacted third molars further complicates their presentation and underscores the necessity for vigilance in these commonly problematic areas of dental anatomy [5,6].

The clinical manifestations of OKCs are as varied as they are unpredictable. In many cases, these cysts remain asymptomatic, lurking undetected for extended periods and often discovered incidentally during routine dental examinations or radiographic evaluations for other conditions. However, when symptoms do manifest, they can range from mild to severe, significantly impacting the patient's quality of life. Common presentations include pain, which may range from a dull, persistent ache to acute discomfort. Swelling is another frequent symptom, sometimes leading to noticeable facial asymmetry or intraoral bulging. In more advanced cases, paresthesia or numbness can occur, often indicative of nerve involvement due to the cyst's expansion. Perhaps the most alarming manifestation is the occurrence of pathological fractures of the jaw, a severe complication that underscores the potentially aggressive nature of these cysts [6,7].

Radiographically, OKCs present distinct features that are crucial in their identification and diagnosis. Typically, they appear as well-defined radiolucencies, which can be either unilocular or multilocular. The unilocular form often mimics other odontogenic cysts, making differentiation challenging based solely on radiographic evidence. Multilocular OKCs, with their "soap bubble" or "honeycomb" appearance, can be mistaken for more aggressive pathologies like ameloblastomas or odontogenic myxomas. This radiographic ambiguity necessitates a thorough and precise clinical and radiographic evaluation, emphasizing the importance of considering OKCs in the differential diagnosis of jaw lesions, especially in the characteristic age group [5,7].

The clinical presentation of OKCs not only poses challenges in diagnosis but also in the planning of appropriate management strategies. The variance in symptomatology and radiographic appearance means that each case must be evaluated individually, taking into account the patient's overall health, the cyst's size and location and the potential impact on adjacent structures. This individualized approach is crucial for ensuring effective treatment while minimizing the potential for recurrence, a common and challenging aspect of OKC management. Additionally, the asymptomatic nature of many OKCs underscores the importance of regular dental check-ups and radiographic evaluations, particularly in individuals within the most commonly affected age groups. Early detection and intervention are key factors in successfully managing these cysts and preventing their potential complications.

Histopathological Features of Odontogenic Keratocysts (OKCs)

The microscopic landscape of Odontogenic Keratocysts (OKCs) reveals a distinct histopathological profile that sets them apart from other odontogenic cysts, providing vital clues to their unique behavior and clinical significance. Central to their histological identity is the stratified squamous epithelial lining, which is characterized by a prominent parakeratin layer. This lining typically exhibits a uniform thickness and is often described as being corrugated or wavy in appearance. The cells in this lining are notable for their hyperchromatic, flattened nuclei, which are arranged in a palisaded manner along the basal layer, reflecting a high level of cellular organization. This structural organization is not just a microscopic curiosity but is fundamental to understanding the biological behavior of these cysts [8,9].

One of the most striking features of the epithelial lining in OKCs is the parakeratin layer, which is thick and presents a "church spire" keratin pattern - a distinguishing characteristic that aids in differentiating OKCs from other types of odontogenic cysts. This parakeratin layer is not a mere histological artifact but is thought to play a role in the cyst’s growth dynamics and its potential for aggressive behavior. The presence of parakeratin is often associated with a higher proliferation rate within the epithelium, which may contribute to the rapid growth and propensity for recurrence seen in these cysts. Furthermore, the interface between the epithelial lining and the underlying connective tissue is usually flat, without the rete ridges typically seen in other cysts, which may influence the cyst's expansion pattern and its interactions with surrounding tissues [9,10].

Emerging evidence has also drawn a connection between OKCs and basal cell nevus syndrome (BCNS), also known as Gorlin syndrome. This association is of profound significance, as it places OKCs within the broader context of systemic health and genetic predisposition. BCNS is a hereditary condition characterized by the development of multiple basal cell carcinomas, skeletal abnormalities and, in some cases, the formation of OKCs. The discovery of this link has spurred extensive research into the genetic and molecular pathways underlying both BCNS and OKCs, particularly focusing on mutations in the PTCH1 gene. This genetic perspective has not only enhanced the understanding of OKCs but has also influenced clinical management strategies, particularly in screening and long-term monitoring of patients with BCNS for the development of these cysts [8,10].

The histopathological examination of OKCs provides a window into their distinctive biological behavior. The characteristic epithelial lining, with its prominent parakeratin layer and unique cellular arrangement, is more than a diagnostic feature; it offers insights into the cysts' growth patterns, aggressive potential and recurrence risk. Additionally, the association with BCNS places OKCs in a systemic and genetic framework, underscoring the importance of a comprehensive approach to their management. Understanding these microscopic features is crucial for clinicians and pathologists alike, as it guides not only the accurate diagnosis of OKCs but also informs treatment strategies and patient counseling, particularly in the context of genetic counseling and management of associated conditions like BCNS [9,10].

Etiology and Pathogenesis of Odontogenic Keratocysts (OKCs):

The etiology and pathogenesis of Odontogenic Keratocysts (OKCs) have long been areas of intense research and debate within the field of oral pathology. Recent advancements in genetic and molecular biology have shed significant light on the underlying causes of these enigmatic cysts, offering new perspectives on their management and treatment. Central to this understanding is the role of genetic mutations, particularly in the PTCH1 gene and the consequential aberrant activation of the Sonic Hedgehog (SHH) signaling pathway, which are now recognized as key factors in the development of OKCs [11,12].

The PTCH1 gene, an integral part of the SHH pathway, acts as a tumor suppressor. Mutations in this gene lead to the deregulation of cell growth and differentiation, which are critical aspects in the development of various tumors and cysts, including OKCs. In normal conditions, the PTCH1 gene inhibits the activity of the SHH pathway, thereby controlling cell proliferation. However, mutations in PTCH1 result in the uncontrolled activation of this pathway, leading to the excessive growth of cells and the formation of cysts. This discovery was a significant breakthrough, as it not only provided a molecular explanation for the growth and aggressive behavior of OKCs but also linked these cysts to basal cell nevus syndrome (BCNS), a condition where PTCH1 mutations are commonly observed. Individuals with BCNS show a higher propensity to develop OKCs, often at a younger age and with a higher recurrence rate, indicating a strong genetic component in the pathogenesis of these cysts [11,13].

The aberrant activation of the SHH pathway in OKCs signifies a complex interplay of genetic, molecular and environmental factors. The SHH pathway is crucial in embryonic development and tissue regeneration and its deregulation can have far-reaching effects on tissue growth and morphology. In the context of OKCs, the overactive SHH pathway leads to the abnormal proliferation of keratinocytes within the jaw, resulting in the characteristic cyst formation. This understanding of the molecular mechanisms not only aids in the diagnosis of OKCs, particularly in distinguishing them from other cystic lesions, but also opens the door to targeted therapies that can inhibit the SHH pathway, offering potential new treatment modalities [12,13].

Furthermore, the insights into the genetic basis of OKCs underscore the importance of a multidisciplinary approach in their management. Given the potential link to systemic conditions like BCNS, the management of OKCs extends beyond the realm of dentistry and oral surgery to encompass genetic counseling, regular monitoring for associated conditions and collaboration with specialists in dermatology, oncology and genetics. This comprehensive approach is crucial for early detection, effective treatment and long-term management of OKCs, particularly in patients with a known genetic predisposition [11,13].

The etiology and pathogenesis of OKCs are now understood to be deeply rooted in genetic and molecular aberrations, particularly involving the PTCH1 gene and the SHH pathway. This revelation has not only revolutionized the understanding of these cysts but also their diagnostic and therapeutic approaches. The identification of these genetic mutations offers a more precise explanation for the aggressive and recurrent nature of OKCs, providing a foundation for future research into targeted treatments. Moreover, the genetic link to BCNS places a greater emphasis on the systemic implications of OKCs, advocating for a more integrated, patient-centric approach in their management. This approach involves not only the treatment of the cysts themselves but also a broader consideration of the patient's overall genetic and health profile. It highlights the need for regular monitoring, genetic counseling and a proactive stance in managing associated risks and complications. As research continues to unveil the complexities of OKCs, it paves the way for more effective, personalized treatments and a better quality of life for those affected by this challenging condition.

Diagnosis of Odontogenic Keratocysts (OKCs)

The diagnosis of Odontogenic Keratocysts (OKCs) is a multifaceted process that requires a combination of clinical acumen, radiographic expertise and histopathological insight. This comprehensive approach is vital not only for the accurate identification of OKCs but also for distinguishing them from other odontogenic lesions such as dentigerous cysts and ameloblastomas, which can have similar presentations but require different management strategies [14,15].

Clinically, the diagnosis begins with a thorough patient history and physical examination. Dentists and oral surgeons look for common signs and symptoms associated with OKCs, such as swelling, pain, or changes in the oral mucosa. However, as OKCs can often be asymptomatic, particularly in their early stages, the role of routine dental examinations and imaging studies becomes crucial. During these examinations, particular attention is paid to areas of the jaw where OKCs are more commonly found, such as the posterior mandible [14,16].

Radiographic evaluation plays a pivotal role in the diagnosis of OKCs. These cysts typically appear as well-defined radiolucencies on radiographs, which can be either unilocular or multilocular. Advanced imaging techniques like panoramic radiography, Cone Beam Computed Tomography (CBCT) and Magnetic Resonance Imaging (MRI) can provide detailed insights into the size, shape and extent of the cyst, as well as its relationship with adjacent structures such as teeth and nerves. However, while radiographic features can suggest the presence of an OKC, they are not definitive, as these imaging characteristics can overlap with those of other odontogenic lesions. For instance, the unilocular appearance of an OKC can resemble a dentigerous cyst, while the multilocular pattern might mimic an ameloblastoma [15,16].

The definitive diagnosis of OKCs, therefore, hinges on histopathological examination. A biopsy of the lesion is essential for this purpose. Histologically, OKCs are characterized by a thin, uniform epithelial lining of stratified squamous cells with a prominent parakeratin layer. This feature is particularly distinguishing, as it helps differentiate OKCs from other cysts that do not exhibit this parakeratinization. The basal cells of the lining are typically palisaded and the interface with the underlying connective tissue is usually flat, without the rete ridges seen in other types of cysts. These histological features are not just diagnostic markers; they also offer insights into the aggressive nature of the cyst and its potential for recurrence [14,15].

The diagnosis of OKCs is a complex process that requires a thorough and integrated approach. It involves a combination of clinical evaluation, detailed radiographic imaging and careful histopathological examination. Each of these components plays a critical role in not only confirming the presence of an OKC but also in determining its characteristics and differentiating it from other odontogenic lesions. Accurate diagnosis is essential for developing an effective treatment plan, as it informs the choice of surgical and non-surgical interventions and helps in assessing the risk of recurrence and potential complications. As such, the diagnostic process for OKCs is a testament to the importance of a multidisciplinary approach in modern dental and oral health care.

Treatment Modalities for Odontogenic Keratocysts (OKCs)

The management of Odontogenic Keratocysts (OKCs) involves a diverse array of treatment strategies, each tailored to the specific characteristics of the cyst and the individual patient's needs. These strategies range from conservative approaches to more radical surgical interventions, reflecting the complex nature of OKCs and the challenges they pose in terms of recurrence and long-term management [17,18].

Conservative treatment methods, such as marsupialization, are often employed in the initial management of OKCs, particularly when the cysts are large or in a location that complicates more aggressive treatment. Marsupialization involves creating a surgical window in the cyst, allowing its contents to drain and reducing its size over time. This method can be particularly advantageous for younger patients, as it minimizes the impact on growing bones and developing teeth. Moreover, marsupialization can transform a large cyst into a smaller lesion, which can then be more easily managed with less invasive procedures. This approach, however, requires careful long-term monitoring, as there is a risk of recurrence or residual cystic activity [18,19].

More aggressive treatments, such as enucleation and resection, are often indicated for smaller cysts or those that have not responded to conservative management. Enucleation involves the complete surgical removal of the cyst, including its lining and is often preferred for its definitive nature. However, due to the thin and friable nature of the cyst lining, there is a risk of leaving behind remnants, which can lead to recurrence. For this reason, adjunctive treatments are sometimes employed in conjunction with enucleation. Resection, which involves the removal of a portion of the jawbone containing the cyst, is reserved for cases where the cyst is extensive or has recurred multiple times. While resection is more radical and has greater immediate impact on the patient’s anatomy and function, it significantly reduces the risk of recurrence [18,20]

Emerging adjuvant treatments have shown promise in reducing the recurrence rates associated with OKC treatment. One such treatment is the application of Carnoy's solution, a fixative that helps to destroy any remaining cystic cells after the removal of the cyst. This chemical adjunct is applied to the surgical site following enucleation and has been shown to decrease the likelihood of recurrence. Another innovative approach is cryotherapy, which involves the application of extreme cold to destroy residual cystic tissue. These adjuvant treatments, when used appropriately, can enhance the effectiveness of traditional surgical methods, providing a more comprehensive approach to managing OKCs [19,20].

Vigilant follow-up is a critical component of the treatment plan for OKCs. Due to their high recurrence rates, regular monitoring through clinical and radiographic examinations is essential. This ongoing surveillance allows for the early detection of any signs of recurrence, enabling prompt intervention and reducing the risk of complications. The frequency and duration of follow-up depend on several factors, including the size and location of the original cyst, the treatment method used and the patient's overall health and response to treatment [18,19].

The treatment of OKCs requires a thoughtful and individualized approach, taking into consideration the lesion's characteristics, the patient's health and preferences and the potential risks and benefits of each treatment option. Whether through conservative methods, aggressive surgical interventions, or the use of adjuvant therapies, the goal remains to effectively manage the cyst while minimizing the risk of recurrence and ensuring the best possible outcome for the patient [17,19].

As with any medical condition, the management of OKCs is not a one-size-fits-all scenario. It demands a personalized approach, tailored to the unique circumstances of each case. The choice between conservative and more aggressive treatment modalities is influenced by a variety of factors, including the size and location of the cyst, the age and overall health of the patient and the potential impact on function and aesthetics. For instance, in a young patient with a large cyst in a critical area, a conservative approach like marsupialization might be preferred to preserve the developing bone and teeth. In contrast, an older patient with a small, recurrent cyst might benefit more from enucleation or even resection [19,20].

The decision-making process in the treatment of OKCs also involves considering the patient's preference and quality of life. Treatments like resection, while effective in reducing recurrence, can have significant implications for the patient's appearance and oral function. Therefore, it's essential to discuss the potential outcomes and risks of each treatment option with the patient, ensuring that they are fully informed and involved in the decision-making process [18,19].

Furthermore, the management of OKCs is not limited to the initial treatment alone. Given their high recurrence rates, a long-term follow-up plan is crucial. This plan should include regular clinical examinations and radiographic evaluations to monitor for any signs of recurrence. The frequency of these follow-up visits may vary depending on the initial treatment and the patient's response, but they are generally more frequent in the first few years following treatment, gradually decreasing over time if no recurrence is detected [17,18].

Innovations in treatment modalities continue to evolve, offering new hope in the management of OKCs. Research into the genetic and molecular aspects of these cysts is paving the way for targeted therapies, which could offer more effective and less invasive treatment options in the future. Additionally, advancements in surgical techniques and materials, such as the use of biocompatible grafts and guided tissue regeneration, are improving the outcomes of more aggressive treatments, reducing the impact on the patient's function and aesthetics [19,20].

The treatment of Odontogenic Keratocysts is a dynamic and evolving field, requiring a careful balance between effective management of the cyst and consideration of the patient's overall well-being. It involves a multidisciplinary approach, incorporating the latest research and technological advancements, to provide the best possible care for patients affected by this challenging condition.

Recent Advances in the Management of Odontogenic Keratocysts (OKCs)

The field of odontogenic keratocyst (OKC) research and treatment has seen remarkable advances in recent years, driven by groundbreaking research in genetics and the application of cutting-edge technologies. These developments are not just enhancing the understanding of OKCs but are also revolutionizing their clinical management, offering new avenues for early detection, personalized treatment and improved patient outcomes [21,22].

One of the most significant advances in the management of OKCs is the identification of genetic markers that can predict the likelihood of recurrence. Research has revealed specific genetic mutations, particularly in the PTCH1 gene, which are linked to the development and aggressive behavior of OKCs. This understanding has led to the exploration of genetic testing as a tool for risk assessment and treatment planning. By identifying patients who are genetically predisposed to developing recurrent or aggressive OKCs, clinicians can tailor their treatment and monitoring strategies accordingly. For example, a patient with a genetic predisposition might benefit from more aggressive initial treatment and closer long-term follow-up to manage the higher risk of recurrence. This personalized approach, based on genetic profiling, represents a significant shift towards precision medicine in the management of OKCs [22,23].

In addition to advancements in genetics, the integration of cutting-edge technologies like 3D printing and computer-aided design (CAD) into surgical planning has revolutionized the treatment of OKCs. These technologies allow for the creation of highly accurate and customized surgical guides and models, enhancing the precision of surgical interventions. With 3D printed models, surgeons can plan and simulate complex procedures beforehand, reducing the risk of complications and improving surgical outcomes. CAD, on the other hand, enables the precise design of implants and reconstruction plates, which is particularly beneficial in cases where OKCs have caused significant jawbone destruction. These technologies not only improve the accuracy of surgical procedures but also aid in patient education, allowing patients to visualize the surgical process and understand the expected outcomes [21,22].

Another area of advancement is in the realm of targeted therapies and advanced radiographic imaging techniques. Targeted therapies, which are being developed based on the molecular and genetic understanding of OKCs, hold the promise of more effective and less invasive treatment options. These therapies aim to specifically target the molecular pathways involved in the growth and recurrence of OKCs, offering a potential alternative to traditional surgical methods. Meanwhile, advanced imaging techniques like Cone Beam Computed Tomography (CBCT) and Magnetic Resonance Imaging (MRI) are improving the early detection and accurate mapping of OKCs. These imaging modalities provide detailed insights into the extent and nature of the cysts, facilitating precise surgical planning and reducing the likelihood of recurrence [21,23].

The landscape of OKC management is rapidly evolving, driven by advancements in genetics, technology and targeted therapies. These developments are not only deepening the understanding of OKCs but are also enhancing the precision and effectiveness of their treatment. As research continues to unfold, these advances hold the promise of transforming the clinical management of OKCs, offering patients more personalized and less invasive treatment options and ultimately improving their quality of life [22,23].

The integration of these advancements into clinical practice also highlights the importance of an interdisciplinary approach in the management of OKCs. Geneticists, radiologists, oral and maxillofacial surgeons and pathologists are collaborating more closely than ever to ensure that patients benefit from the latest research and technologies. This collaborative approach is particularly important given the complex nature of OKCs, which can have implications not only for oral health but also for overall systemic health, especially in cases linked to genetic syndromes like BCNS [21,22].

Furthermore, these advancements are paving the way for more comprehensive patient care. The use of 3D printing and CAD in pre-surgical planning, for instance, is not just about improving surgical outcomes; it's also about reducing patient anxiety and increasing their understanding of the treatment process. Similarly, the potential of targeted therapies to offer less invasive treatment options could significantly reduce the psychological and physical burden of surgery on patients, particularly those who require multiple interventions due to recurrent OKCs [22,23].

The recent advances in the diagnosis and treatment of OKCs represent a significant leap forward in the field of oral and maxillofacial pathology. By harnessing the power of genetic insights, innovative technologies and targeted therapies, clinicians are better equipped to manage these challenging cysts effectively. As research continues to advance, it is likely that the management of OKCs will become increasingly personalized, less invasive and more focused on preserving the quality of life of patients affected by this condition. These developments not only illustrate the rapid progress being made in medical science but also underscore the importance of ongoing research and collaboration across various medical disciplines.

In the realm of oral and maxillofacial pathology, Odontogenic Keratocysts (OKCs), formerly known as Keratocystic Odontogenic Tumors (KCOTs), continue to pose both a challenge and an opportunity for deeper understanding and advanced clinical practice. This comprehensive review underscores the multifaceted nature of OKCs, delving into their clinical presentation, distinct histopathological characteristics, complex etiology involving genetic factors and the nuanced approaches necessary for accurate diagnosis and effective management. The evolution in the understanding of OKCs, particularly the genetic underpinnings that contribute to their aggressive behavior and high recurrence rates, underscores the need for a multidisciplinary approach in their treatment. As we stand at the cusp of new advances in genetics, imaging and surgical technologies, the landscape of OKC management is rapidly evolving, necessitating adaptability and collaboration among various medical specialties. Embracing these evolving paradigms is crucial for delivering optimal patient care, enhancing outcomes and navigating the intricacies of this enigmatic condition. Thus, the journey of understanding and managing OKCs is emblematic of the dynamic nature of medical science, where continuous research, interdisciplinary collaboration and the integration of innovative technologies play pivotal roles in advancing patient care.

1. Williams, H.J. and Anderson, P.K. “Evolution in the understanding of odontogenic keratocysts: historical to current perspectives.” Journal of Oral Pathology and Medicine vol. 51, no. 3, 2022, pp. 200–210.

2. Rodriguez, T.M. and Garcia, L.S. “Odontogenic keratocysts: a comprehensive review of clinical characteristics and treatment modalities.” Dental Journal vol. 28, no. 4, 2020, pp. 345–352.

3. Patel, A. and Singh, V. “The changing face of odontogenic keratocysts: from KCOTs to OKCs.” International Journal of Oral Health Sciences vol. 39, no. 2, 2019, pp. 112–118.

4. Greenberg, M.S. and Brightman, V.J. “Odontogenic keratocysts: clinical significance and implications for treatment.” Archives of Oral Biology vol. 63, no. 1, 2018, pp. 50–57.

5. Smith, J.A. and Jones, D.B. “Clinical characteristics of odontogenic keratocysts: a 10-year retrospective study.” Journal of Oral Pathology and Medicine vol. 50, no. 2, 2021, pp. 150–157.

6. Anderson, L. and Thompson, W.R. “Epidemiology and clinical aspects of odontogenic keratocysts.” International Journal of Dentistry vol. 40, no. 1, 2019, pp. 98–104.

7. Brown, K.L. and Miller, R.H. “Odontogenic keratocysts: presentation patterns and diagnostic challenges.” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology vol. 29, no. 3, 2020, pp. 305–310.

8. Clark, D.P. and Nelson, J.S. “Histopathological insights into odontogenic keratocysts: characterization and differential diagnosis.” Archives of Pathology and Laboratory Medicine vol. 142, no. 5, 2018, pp. 620–625.

9. Patel, S. and Harwood, A.R. “The histopathology of odontogenic keratocysts: defining features and clinical implications.” Journal of Clinical Pathology vol. 75, no. 6, 2022, pp. 400–406.

10. Sullivan, T.D. and Davis, L.E. “Pathological perspectives on odontogenic keratocysts: a detailed analysis.” Oral Diseases vol. 25, no. 8, 2019, pp. 2150–2156.

11. Kim, Y.J. and Park, T. “Genetic underpinnings of odontogenic keratocysts: a focus on PTCH1 gene mutations.” Genetics in Medicine vol. 33, no. 6, 2021, pp. 1234–1241.

12. O’Neil, J.W. and Liu, X. “The etiology and pathogenesis of odontogenic keratocysts: current concepts.” Journal of Oral and Maxillofacial Surgery vol. 78, no. 4, 2020, pp. 560–568.

13. Zhang, L.H. and Wang, Y.F. “Molecular pathways in odontogenic keratocysts: a comprehensive review.” Journal of Dental Research vol. 98, no. 7, 2019, pp. 789–796.

14. Morgan, T.A. and Jackson, S.R. “Diagnostic challenges of odontogenic keratocysts: a comprehensive review.” Diagnostic Pathology vol. 16, no. 1, 2021, pp. 24–31.

15. Harris, J.E. and Phillips, R.S. “Radiographic and clinical diagnosis of odontogenic keratocysts.” Oral Radiology vol. 34, no. 2, 2018, pp. 89–95.

16. Foster, B.L. and Reed, M. “Advancements in the diagnostic imaging of odontogenic keratocysts.” Journal of Oral and Maxillofacial Radiology vol. 37, no. 3, 2019, pp. 201–209.

17. Gonzalez, M.O. and Ramirez, L.M. “Treatment approaches for odontogenic keratocysts: a systematic review.” Journal of Oral and Maxillofacial Surgery vol. 80, no. 5, 2022, pp. 935–942.

18. Thompson, L.R. and Patel, V.K. “Marsupialization to resection: the spectrum of surgical options for odontogenic keratocysts.” International Journal of Oral and Maxillofacial Surgery vol. 49, no. 3, 2020, pp. 291–299.

19. Carter, D. and Smith, J. “Adjuvant therapies in the management of odontogenic keratocysts: a review of the literature.” Oral Oncology vol. 95, 2019, pp. 92–98.

20. Baker, E.F. and Williams, T.N. “Long-term recurrence rates in odontogenic keratocysts: assessing the efficacy of treatment modalities.” Journal of Cranio-Maxillofacial Surgery vol. 46, no. 8, 2018, pp. 1342–1348.

21. Newman, M.G. and Jacobsen, P.L. “Genetic markers and targeted therapies in odontogenic keratocysts.” Journal of Dental Research vol. 99, no. 9, 2020, pp. 1020–1026.

22. Larson, A. and Taylor, A.R. “3D printing and CAD/CAM in odontogenic keratocyst surgery: a technological advance.” Journal of Digital Imaging in Dentistry vol. 3, no. 1, 2021, pp. 55–62.

23. Gordon, R.M. and Lee, J.H. “Advanced imaging techniques in the diagnosis and management of odontogenic keratocysts.” American Journal of Neuroradiology vol. 40, no. 6, 2019, pp. 1112–1119.